Phase I study of recombinant human tumor necrosis factor.
about
Selective enhancement of thrombopoietic activity of PEGylated interleukin 6 by a simple procedure using a reversible amino-protective reagent.Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicineDevelopment of a novel DDS for site-specific PEGylated proteins.Systemic use of tumor necrosis factor alpha as an anticancer agentSelective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibodyMolecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency.Evaluation of the role of nuclear factor-kappaB signaling in liver injury using genetic animal models.Intracellular survival pathways in the liver.Optimization of protein therapies by polymer-conjugation as an effective DDS.Therapeutic applications of TRAIL receptor agonists in cancer and beyond.Development of novel drug delivery systems using phage display technology for clinical application of protein drugsTumour necrosis factor: a cytokine with multiple biological activities.Targeting TRAIL in the treatment of cancer: new developments.Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis.TNF-dependent signaling pathways in liver cancer: promising targets for therapeutic strategies?.Linkage with cathepsin B-sensitive dipeptide promotes the in vitro and in vivo anticancer activity of PEGylated tumor necrosis factor-alpha (TNF-α) against murine fibrosarcoma.Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.Tumor necrosis factor-alpha stimulates colony formation by a megakaryoblastic leukemia cell line, CMK.Human tumor-infiltrating lymphocytes transfected with tumor necrosis factor gene could augment cytotoxicity to autologous tumor cells.Enzymic degradation of plasma arginine using arginine deiminase inhibits nitric oxide production and protects mice from the lethal effects of tumour necrosis factor alpha and endotoxin.Nutrition and cytokine action.NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration.Lysosome labilizers potentiate the antitumor effects of tumor necrosis factor-alpha.The potential of serum levels of soluble tumour necrosis factor receptor I as a biochemical marker in cervical cancerUnleashing endogenous TNF-alpha as a cancer immunotherapeutic
P2860
Q31893425-D20DC30C-9D4A-48E1-AF91-2B91DC5CBC7AQ33325343-F03811AC-13BD-4139-A7D1-EB54971D671FQ33575382-CD3E87C0-196B-43E7-935C-BD5F730388DCQ34419681-F0D243DF-1F52-4345-AA36-EAD7EA911ED7Q35040200-7181362C-8EC9-4BAC-BB98-F064416C2BB3Q35640180-3B400302-5966-4114-B836-D569D084677AQ35994055-AED739D8-D15A-417F-B28F-8409DCC96F9EQ36080891-5D9DBC80-446B-4F93-B7F3-D879F81F6908Q36588203-5D1A363E-9076-41C4-A6F6-1A8140841291Q36653854-B50DE6FB-3896-44AF-8E4F-FB4BE87457F0Q37002679-79D8EFE5-8BD0-49E6-B655-C7146E59D367Q37114025-220EAD02-2BF0-463B-B907-82E5563907C2Q37198453-1187C4A1-2E81-4568-81D1-ED203203894DQ37916679-EC1585F4-2213-4586-A5E9-F413CD82ED3AQ38500801-85CEC6CA-FD5E-4148-A598-8D4C2E9E6A1BQ38851623-C1034A1E-236A-4C2E-9A5B-05DC6152E43DQ39529070-08F2708E-B794-4CCD-B467-165AA6FABBF5Q39592845-7A9FD0A8-FF35-4886-9AD6-73BFCE458A19Q40069409-F5F774E5-76AF-4FF6-B2CF-1CAF1D75BFFEQ41605194-997630A8-886C-4407-84F5-C8654BFBDF61Q41658455-A9283D7C-2A9A-4934-84F2-8765E6BC1C10Q43001528-D4AE86E2-05B3-4B95-98C9-302041AB60BEQ53808732-2253034C-0194-4421-B926-9B442C46E0C6Q54064832-97AF4EBE-CE0E-4B5E-8729-8D1CF2D66C27Q54960071-80B28EEF-09D5-4802-925B-F747EEC684E6Q58377258-A4E81E07-0200-4FD2-BAB9-737A8F61766AQ58781970-78202001-D3ED-450D-BDF5-3993BA86749B
P2860
Phase I study of recombinant human tumor necrosis factor.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Phase I study of recombinant human tumor necrosis factor.
@ast
Phase I study of recombinant human tumor necrosis factor.
@en
type
label
Phase I study of recombinant human tumor necrosis factor.
@ast
Phase I study of recombinant human tumor necrosis factor.
@en
prefLabel
Phase I study of recombinant human tumor necrosis factor.
@ast
Phase I study of recombinant human tumor necrosis factor.
@en
P2093
P356
P1476
Phase I study of recombinant human tumor necrosis factor.
@en
P2093
H Ichihashi
I Urushizaki
K Inoguchi
P2888
P304
P356
10.1007/BF00570490
P577
1987-01-01T00:00:00Z
P6179
1032993151